Developing medicines for women's sexual health
Specialists in women's sexual health
Difficulty reaching orgasm is one of the most common sexual concerns women report, yet there is no FDA-approved medication for it. The sexual health medicines approved for women address desire, not orgasm.
CTFOD Pharmaceuticals builds on years of peer-reviewed research into female sexual response. We are developing a targeted treatment within the FDA's drug development framework, working with experienced regulatory advisors toward controlled clinical trials.
Research-driven
Grounded in published research on female orgasm and the factors that influence it.
Rigorous development
Designed for controlled clinical trials and regulatory review from the start.
Dr. Mulvehill is a clinical sexologist, scientist and researcher whose work focuses on female orgasm difficulty. She has spent nearly a decade studying female sexual response, conducting research and developing clinical models for its treatment. Her work is also informed by more than 30 years of her own experience with orgasm difficulty and its resolution.
- Author of peer-reviewed research on female orgasm, including a published systematic review
- Author of a chapter on sexual dysfunction for Elsevier
- Presenter at international scientific conferences
- Founder of the Female Orgasm Research Institute, a 501(c)(3) research nonprofit
- Serial entrepreneur who founded and sold an international wholesale business